Most US Adults With T2D Meet Criteria for GLP-RAs, SGLT2is
Most US adults with T2D meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10% use either, according to a research...
Read More